Article

Intranasal inhibitor blocks omicron and other variants of SARS-CoV-2

2021-12-28

Abstract excerpt

<title>Abstract</title> <p>The emergence of the SARS-CoV-2 Omicron variant capable of escaping neutralizing antibodies emphasizes the need for prophylactic strategies to complement vaccination in fighting the COVID-19 pandemic. Nasal epithelium is rich in the ACE2 receptor and important for SARS-CoV-2 transmission by supporting early viral replication before seeding to the lung1. Intranasal administration of SARS...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 89d734c1-44bf-5aef-be71-87e860f5c3c9
DOI: 10.21203/rs.3.rs-1196079/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Intranasal inhibitor blocks omicron and other variants of SARS-CoV-2DOI 10.21203/rs.3.rs-1196079/v1Read

Intranasal inhibitor broadly blocks SARS-CoV-2 including recent highly immunoevasive Omicron subvariantsSemantic proximity Read

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shiftSemantic proximity Read

An ACE2-blocking antibody confers broad neutralization and protection against Omicron and other SARS-CoV-2 variantsSemantic proximity Read

An engineered ACE2 decoy receptor can be administered by inhalation and potently targets the BA.1 and BA.2 omicron variants of SARS-CoV-2Semantic proximity Read

Discovery of a SARS-CoV-2 Broadly-Acting Neutralizing Antibody with Activity against Omicron and Omicron + R346K VariantsSemantic proximity Read

An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivoSemantic proximity Read

Engineered ACE2 counteracts vaccine-evading SARS-CoV-2 Omicron variantSemantic proximity Read

Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptidesSemantic proximity Read

A novel highly potent inhibitor of TMPRSS2-like proteases blocks SARS-CoV-2 variants of concern and is broadly protective against infection and mortality in miceSemantic proximity Read

Protein scaffold-based multimerization of soluble ACE2 efficiently blocks SARS-CoV-2 infection <i>in vitro</i> and <i>in vivo</i>Semantic proximity Read

Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strainsSemantic proximity Read

Omicron Spike confers enhanced infectivity and interferon resistance to SARS-CoV-2 in human nasal tissueSemantic proximity Read